Addressing Unmet Needs for Cholangiocarcinoma & Myeloid Lymphoid Neoplasms
ASCO GI 2023 Phase 3 Randomized SWOG 1815 Trial: Gemcitabine, Cisplatin, & nab-Paclitaxel vs. Gemcitabine & Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
By
ASCO GI 2023 Conference Coverage
FEATURING
Rachna Shroff
By
ASCO GI 2023 Conference Coverage
FEATURING
Rachna Shroff
Login to view comments.
Click here to Login